Pfizer Rises 4.5% on Q2 Beats, Raised Guidance

Pfizer (NYSE:PFE) investors are having a good Tuesday. Their company reported second-quarter fiscal results in the morning, and while headline numbers declined, they handily beat analyst estimates.

For the quarter, the pharmaceutical giant's revenue came in at just over $11.80 billion -- 11% below the Q2 2019 tally. On the bottom line, non-GAAP (adjusted) net profit was down by 3% at $4.40 billion, or $0.78 per share.